Stroke Trial, Recruiting (NCT05983185)

Stroke Trial, Recruiting NCT05983185 Sponsor: VA Office of Research and Development Condition: Stroke

Printed from Voxsanity (voxsanity.com.au) — NCT05983185 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Stroke

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have had their first stroke affecting the right side of the brain, and who are over 18 years of age
People who are between 1 and 4 months since being diagnosed with a right brain stroke
People who are able to sit up, see out of both eyes with vision of at least 20/50 (with both eyes open), and point to objects
People who are able to understand and agree to participate in the trial by giving informed consent

Who may not be able to join:

People who have been diagnosed with another ongoing, disabling neurological condition, such as multiple sclerosis or Alzheimer's disease
People who have had a stroke affecting the left side of the brain, or whose brain scans show signs of previous strokes, including more than two small areas of damage larger than 15mm in diameter
People who are unable to sit up during testing and treatment
People whose vision, when using both eyes together, is worse than 20/50

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 13 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Anna M. Barrett, MD, VA Central Western Massachusetts Healthcare System, Leeds, MA

Phone: (508) 856-0104

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05983185

Sponsor: VA Office of Research and Development

Phase: Not Applicable

Status: Recruiting

Condition: Stroke

Trial contact: (508) 856-0104

More information: https://clinicaltrials.gov/study/NCT05983185

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have had their first stroke affecting the right side of the brain, and who are over 18 years of age
People who are between 1 and 4 months since being diagnosed with a right brain stroke
People who are able to sit up, see out of both eyes with vision of at least 20/50 (with both eyes open), and point to objects
People who are able to understand and agree to participate in the trial by giving informed consent

Who may not be able to join:

People who have been diagnosed with another ongoing, disabling neurological condition, such as multiple sclerosis or Alzheimer's disease
People who have had a stroke affecting the left side of the brain, or whose brain scans show signs of previous strokes, including more than two small areas of damage larger than 15mm in diameter
People who are unable to sit up during testing and treatment
People whose vision, when using both eyes together, is worse than 20/50

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 13 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

VA Office of Research and Development

Registry

ClinicalTrials.gov

Start date

1 February 2023

Est. completion

31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Spatial neglect (SN) type (Aiming SN versus Where SN); Functional independence Measure (FIM) improvement trajectory

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov